fluorodeoxyglucose f18 has been researched along with Coronary Occlusion in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kiko, T; Kunii, H; Masuda, A; Misaka, T; Nakazato, K; Takeishi, Y; Yamaki, T; Yokokawa, T; Yoshihisa, A | 1 |
| Fang, W; He, ZX; Li, S; Shen, R; Sun, XX; Tian, YQ; Wei, H | 1 |
| Bax, JJ; Delgado, V; Ng, ACT | 1 |
| Dou, KF; Fang, W; Feng, L; He, ZX; Lu, MJ; Wang, J; Wang, L; Yang, MF; Zhao, SH | 1 |
| Kramer, CM; Löffler, AI | 1 |
| Blackwood, KJ; Butler, J; Keenliside, L; Mikami, Y; Prato, FS; Sykes, J; Thiessen, JD; Thompson, RT; White, JA; Wisenberg, G | 1 |
1 review(s) available for fluorodeoxyglucose f18 and Coronary Occlusion
| Article | Year |
|---|---|
Myocardial Viability Testing to Guide Coronary Revascularization.
Topics: Chronic Disease; Coronary Occlusion; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2018 |
5 other study(ies) available for fluorodeoxyglucose f18 and Coronary Occlusion
| Article | Year |
|---|---|
Myocardial viability with chronic total occlusion assessed by hybrid positron emission tomography/magnetic resonance imaging.
Topics: Aged; Chronic Disease; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Percutaneous Coronary Intervention; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function; Stroke Volume; Ventricular Function, Left | 2021 |
Preserved myocardial viability in patients with chronic total occlusion of a single coronary artery.
Topics: Aged; Collateral Circulation; Coronary Circulation; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Radiopharmaceuticals; Retrospective Studies; Technetium Tc 99m Sestamibi; Tissue Survival; Tomography, Emission-Computed, Single-Photon | 2021 |
Hybrid Positron emission tomography/magnetic resonance imaging in viability assessment.
Topics: Coronary Occlusion; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Percutaneous Coronary Intervention; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function; Stroke Volume; Ventricular Function, Left | 2021 |
Relationship of myocardial hibernation, scar, and angiographic collateral flow in ischemic cardiomyopathy with coronary chronic total occlusion.
Topics: Aged; Cardiomyopathies; Contrast Media; Coronary Angiography; Coronary Occlusion; Female; Fluorodeoxyglucose F18; Gadolinium; Heart; Heart Failure; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron Emission Tomography Computed Tomography; Retrospective Studies; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 2019 |
Can the inflammatory response be evaluated using 18F-FDG within zones of microvascular obstruction after myocardial infarction?
Topics: Animals; Coronary Circulation; Coronary Occlusion; Coronary Vessels; Dogs; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Image Processing, Computer-Assisted; Inflammation; Macrophages; Magnetic Resonance Imaging; Microcirculation; Multimodal Imaging; Myocardial Infarction; Pentetic Acid; Positron-Emission Tomography; Reproducibility of Results; Technetium; Time Factors | 2015 |